Macedonia Community Development Corporation Receives $150,000 From the Amgen Foundation to Support Business Accelerator Program
- World stocks edge back, bond yields, COVID-19 cases rise
- Canadian National (CNI) Plans to Make $30B Topping Bid for Kansas City Southern (KSU) - DJ
- Analysts Positive, Raise PTs as IBM (IBM) Tops Market Estimates and Reaffirms Guidance
- Tesla's (TSLA) Musk says data logs from crashed vehicle show Autopilot was not enabled, car did not purchase FSD
- Oil hits $68 on Libya force majeure despite pandemic surge
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Funds will support local entrepreneurs and advance economic development in Watts and South Los Angeles
LOS ANGELES--(BUSINESS WIRE)-- Macedonia Community Development Corporation (Macedonia CDC) today announced it has been awarded $150,000 from the Amgen Foundation to support its Watts Entrepreneur Business Accelerator (WEBA) program. The program provides technical assistance and access to capital to entrepreneurs and existing businesses in Watts and surrounding communities as well as businesses that hire Watts residents.
Through WEBA, entrepreneurs gain skills and access to resources that are required to build sustainable businesses and communities. The program provides in-depth business counseling, classroom training, and peer-to-peer learning and covers areas such as business plan development, marketing, permits and licensing, web development and more.
“Macedonia CDC is playing an important role in addressing economic inequality by focusing on providing the support that is required for entrepreneurs to thrive,” said Eduardo Cetlin, President of the Amgen Foundation. “When people have access to these critical business resources, they become empowered to seize opportunities. I look forward to seeing the companies that this program will launch and grow.”
“The generous support of the Amgen Foundation allows us to continue meeting the needs of local entrepreneurs and equipping them to be successful,” said Shane Scott, Macedonia CDC Chairman and CEO. “This is a great example of how our partnerships with public and private entities benefit Watts and directly advance historically marginalized communities.”
Macedonia CDC launched the WEBA program in 2017. One-on-one technical assistance is available Monday through Friday. For more information about Macedonia CDC and its WEBA program, please visit https://macedoniacdc.org.
About the Amgen Foundation
The Amgen Foundation seeks to advance excellence in science education to inspire the next generation of innovators and invest in strengthening communities where Amgen staff members live and work. To date, the Foundation has donated over $325 million to local, regional, and international nonprofit organizations that impact society in inspiring and innovative ways. The Amgen Foundation brings the excitement of discovery to the scientists of tomorrow through several signature programs, including Amgen Scholars and the Amgen Biotech Experience. For more information, please visit AmgenInspires.com.
About Macedonia Community Development Corporation
The Macedonia Community Development Corporation (Macedonia CDC) was founded in 2015 to transform Watts and greater South Los Angeles into vibrant, healthy communities of productive citizens. Through tailored programming and partnerships with public and private entities, Macedonia CDC inspires, supports and empowers the people of Watts. For more information, please visit https://macedoniacdc.org.
Julia Bonner, firstname.lastname@example.org
Source: Macedonia Community Development Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- WeWork Starts Utilizing Cryptocurrency as Form of Payment
- XL Fleet Bolsters Executive Team with Appointment of Cielo M. Hernandez as Chief Financial Officer
- Verizon Communications to report earnings April 21, 2021
Create E-mail Alert Related CategoriesBusiness Wire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!